Quality in Medicare Advantage plans is increasing, and CMS credits the improvement to its star rating system. A growing number of Medicare enrollees are in plans receiving at least 4 out of 5 stars, according to a new fact sheet.
Quality in Medicare Advantage (MA) plans is increasing, according to a CMS fact sheet on the results of the 2015 star ratings. A total of 16 plans earned 5-star ratings, 11 of which are MA with prescription drug coverage (MA-PD), 2 are MA only, and 3 are Prescription Drug Plans (PDPs).
On average, MA-PD plans received 3.92 stars (weighted by enrollment), which is an increase from 3.86 in 2014. The average rating for PDPs is up to 3.75 from 3.05 in 2014. CMS made it clear that it credits the star rating system with the improved quality of MA plans.
“Star Ratings are driving improvements in Medicare quality,” the fact sheet notes.
Furthermore, 53% of PDP enrollees and 60% of MA-PD enrollees are in plans with 4 or more stars, up from 9% and 52%, respectively, in 2014. In addition to an increase in the number of beneficiaries in high-performing MA plan, there was a dramatic improvement in low-performing plans. Low-performing plans received consistently low quality ratings in the past 3 years.
“CMS saw dramatic improvement among plans that received the low performing icon (LPI) in 2014, and many are not receiving an LPI for 2015,” according to the fact sheet from CMS.
Compared with last year, there was an 80% reduction in the number of contracts receiving an LPI for the 2015 star ratings. In 2014, 39 contracts received an LPI and consequently 65% of those that did not withdraw from the program improved their ratings.
Overall, non-profit organizations tend to receive higher ratings than for-profit ones, according to the data from CMS. Among the 14 MA-PD and the PDP contracts that received 5 stars, only 1 was a for-profit organization.
Another factor influencing star ratings was experience within the MA program. All but 1 of the MA-PD 5-star plans have been participating in the program for greater than 10 years. All of the PDP 5-star plans have been part of the program for between 5 and 10 years.
Read the full CMS fact sheet: http://bit.ly/1w8FlKz
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Reducing Low-Value Care Is Hard, but What About Just Not Paying for It?
March 14th 2024After years of efforts to reduce low-value care, panelists at the 2024 Value-Based Insurance Design Summit proposed a new strategy: drawing a line in the sand that payers will not be on the hook for these services.
Read More